CClinicalTrials.gg
CompletedNCT01522222PEEPUpdated Dec 14, 2018

Study to Determine if Using Ventilation During Open Heart Surgery Improves Lung Outcomes

An interventional study of continuous, mechanical ventilatory support in Coronary Artery Disease and Heart Failure, sponsored by Aurora BayCare Medical Center. Completed at 1 site in United States. Per ClinicalTrials.gov, last updated 2018-12-14.

Sponsored by Aurora BayCare Medical Center · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Randomized
Sex
All
01

Study summary

To demonstrate that using continuous mechanical lung ventilatory support in combination with Positive End Expiratory Pressure (PEEP)during open heart surgery will improve lung function and decrease lung complications after surgery.

Read the detailed description

This is a prospective, randomized, blinded study with a control group. The study group will receive mechanical ventilatory support during CBB, which consists of a preset/predetermined tidal volume, respiratory rate, positive pressure at the end of expiration and FIO2. The control group will receive CPB without additional mechanical ventilatory support during surgery, which at present is the standard of care.

The difference between the study and the control group will occur during the time the heart is arrested and the lungs, under present standard of care, are no longer ventilated. It is at this point in time that those in the study group will continue to receive ventilation, intermittent positive pressure ventilation, while their heart is arrested. The subjects will have their lungs ventilated six times per minute with a tidal volume equal to 7-10 milliliters per kilogram. This range, when combined with a consistent PEEP of 5cm of water pressure, will allow for the peak inspiratory pressure to be maintained at or below 40cm of water pressure. In addition, the FIO2 will remain consistent at the same level that was needed to maintain the pulse oximetry at 94% as well as the end-tidal CO2 at 35mmHg. The values mentioned for this study have been chosen based on not only investigator preference, but also on what is considered "minimally necessary" to prevent atelectasis. Multiple studies have been done utilizing PEEP at 5 and 10 cm of water pressure. With the exception of the potential for mechanical ventilation during the CBP, the care of the subject, regardless of the group randomized into, will be the same. We will in all other aspects continue to utilize the current standard of care.

02

Conditions studied

  • Coronary Artery Disease
  • Heart Failure

Keywords

  • cardiopulmonary bypass surgery
  • CABG
  • PEEP
03

In context

Coronary Artery Disease

5,598 studies on the registry are indexed under Coronary Artery Disease; 957 are open to participants now.

This study's enrollment of 40 is below the median of 124 across 3,436 interventional studies indexed under Coronary Artery Disease.

Browse Coronary Artery Disease studies →

Lead sponsor

This is the only study on the registry with Aurora BayCare Medical Center as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • any patient of any gender, any age with known coronary artery disease that will undergo elective Coronary Artery Bypass Grafting (CABG) and will require CPB as part of his/her operative technique.

Exclusion criteria

Exclusion Criteria:

  • documented ejection fraction (either by echocardiogram or by cardiac catheterization) equal to or below 20%
  • patients with cardiac valvular disease
  • patients with a spirometry measurement that demonstrates an FEV1/FVC ratio below 60%
  • patients with chronic renal failure who require dialysis or
  • those who have experienced an allergic reaction to anesthesia in the past
  • patients with a history of lung infiltrate on chest X-ray prior to surgery or a history of asthma
  • Women who are pregnant are excluded
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Care provider, Investigator)
Enrollment
40 participants (actual)

Study arms

  • No intervention
    Control

    half of the study subjects will receive standard of care during their open heart surgery.

  • Experimental
    Treatment

    half of the study subjects will receive the prescribed ventilatory support during open heart surgery.

    Procedure: continuous, mechanical ventilatory support

Interventions

  • Procedurecontinuous, mechanical ventilatory support

    Those in the treatment group will receive ventilation, intermittent positive pressure ventilation, while their heart is arrested. The subjects will have their lungs ventilated six times per minute with a tidal volume equal to 7-10 milliliters per kilogram. This range, when combined with a consistent PEEP of 5cm of water pressure, will allow for the peak inspiratory pressure to be maintained at or below 40cm of water pressure. In addition, the FIO2 will remain consistent at the same level that was needed to maintain the pulse oximetry at 94% as well as the end-tidal CO2 at 35mmHg.

06

What researchers measure

Primary outcomes

  1. Post-surgical lung function, compliance, tissue oxygenation, and radiographic changes indicative of atelectasis.

    Determination if ventilation during surgery improves post-surgical lung function, compliance, tissue oxygenation, and radiographic changes indicative of atelectasis.

    Time frame: During in-patient stay

07

Study locations

1 site
  • Aurora BayCare Medical Center
    Green Bay, Wisconsin 54311, United States
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 14, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01522222
Lead sponsor
Aurora BayCare Medical Center
Responsible party
Raul Mendoza-Ayala (Pulmonologist, Aurora BayCare Medical Center) — Principal investigator
First posted
Jan 31, 2012
Start date
Jul 2010
Primary completion
Sep 29, 2015
Completion
Sep 29, 2015
Last update
Dec 14, 2018

Study contacts

Raul Mendoza-Ayala, MD
principal investigator · Wake Forest University Health Sciences

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion